The Degree of COVID-19 and Preeclampsia at Dr. Soebandi Hospital, Jember
Downloads
Introduction: The risk of preeclampsia increases due to COVID-19. COVID-19 was the leading cause of Indonesia's high maternal mortality rate in 2021, with 2,982 cases. COVID-19 cases affected the maternal mortality rate in East Java, reaching 234.7 per 100,000 live births. Jember ranks first with the highest number of deaths of pregnant women in East Java. This study aimed to examine the relationship between the severity of COVID-19 and the degree of preeclampsia at Dr. Soebandi Hospital, Jember.
Methods: This was an analytic observational study with a cross-sectional design. This study was conducted from March to April 2023. A total of 27 samples of pregnant women with COVID-19 were taken using the total sampling method in 2020-2022 at Dr. Soebandi Hospital, Jember, and analyzed using SPSS with the Spearman statistical test.
Results: This study found that pregnant women with mild cases of COVID-19 were 9 cases, 16 cases were moderate, and 2 cases were severe. There were 15 cases of pregnant women with no preeclampsia and 12 cases with severe preeclampsia.
Conclusion: There was no relationship between the severity of COVID-19 and the degree of preeclampsia at Dr. Soebandi Hospital, Jember.
Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. Am J Obstet Gynecol 2020; 222: 521–531.
Indonesia KKR. Profil Kesehatan Indonesia Tahun 2021. Jakarta, https://www.kemkes.go.id/downloads/resources/download/pusdatin/profil-kesehatan-indonesia/Profil-Kesehatan-2021.pdf (2021).
Dinas Kesehatan Provinsi Jawa Timur. Profil Kesehatan Dinas Kesehatan Provinsi Jawa Timur 2021. Dinas Kesehat Provinsi Jawa Timur 2021; Tabel 53.
Ramanathan K, Antognini D, Combes A, et al. Planning and Provision of ECMO Services for Severe ARDS during the COVID-19 Pandemic and Other Outbreaks of Emerging Infectious Diseases. Lancet Respir Med 2020; 8: 518–526.
Papageorghiou AT, Deruelle P, Gunier RB, et al. Preeclampsia and COVID-19: Results from the INTERCOVID Prospective Longitudinal Study. Am J Obstet Gynecol 2021; 225: 289.e1-289.e17.
Prabhu M, Cagino K, Matthews KC, et al. Pregnancy and Postpartum Outcomes in a Universally Tested Population for SARS-CoV-2 in New York City: A Prospective Cohort Study. BJOG 2020; 127: 1548–1556.
Djuanda JK, Akbar MA, Sulistyono A, et al. Impact of Preeclampsia on the Outcome of COVID-19 Infection. Bali Med J 2023; 12: 1342–1346.
Mendoza M, Garcia-Ruiz I, Maiz N, et al. Pre-eclampsia-Like Syndrome Induced by Severe COVID-19: A Prospective Observational Study. BJOG An Int J Obstet Gynaecol 2020; 127: 1374–1380.
Grechukhina O, Greenberg V, Lundsberg LS, et al. Coronavirus Disease 2019 Pregnancy Outcomes in a Racially and Ethnically Diverse Population. Am J Obstet Gynecol MFM 2020; 2: 100246.
Wu Y, Zhang C, Liu H, et al. Perinatal Depressive and Anxiety Symptoms of Pregnant Women during the Coronavirus Disease 2019 Outbreak in China. Am J Obstet Gynecol 2020; 223: 240.e1-240.e9.
Moyer CA, Compton SD, Kaselitz E, et al. Pregnancy-Related Anxiety during COVID-19: A Nationwide Survey of 2740 Pregnant Women. Arch Womens Ment Health 2020; 23: 757–765.
Science Brief: Indicators for Monitoring COVID-19 Community Levels and Making Public Health Recommendations. Atlanta (GA), 2020.
Guida JP, Cecatti JG, Souza RT, et al. Preeclampsia among Women with COVID-19 during Pregnancy and Its Impact on Maternal and Perinatal Outcomes: Results from a National Multicenter Study on COVID in Brazil, the REBRACO Initiative. Pregnancy Hypertens 2022; 28: 168–173.
Rosenbloom JI, Raghuraman N, Carter EB, et al. Coronavirus Disease 2019 Infection and Hypertensive Disorders of Pregnancy. American Journal of Obstetrics and Gynecology 2021; 224: 623–624.
Coronado-Arroyo JC, Concepción-Zavaleta MJ, Zavaleta-Gutiérrez FE, et al. Is COVID-19 a Risk Factor for Severe Preeclampsia? Hospital Experience in a Developing Country. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2021; 256: 502–503.
Adhikari EH, Moreno W, Zofkie AC, et al. Pregnancy Outcomes among Women with and without Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Netw Open 2020; 3: e2029256.
Quinaglia T, Shabani M, Breder I, et al. Coronavirus Disease-19: The Multi-Level, Multi-Faceted Vasculopathy. Atherosclerosis 2021; 322: 39–50.
Chiarello DI, Abad C, Rojas D, et al. Oxidative Stress: Normal Pregnancy versus Preeclampsia. Biochim Biophys acta Mol Basis Dis 2020; 1866: 165354.
Shim SH, Jeon HJ, Ryu HJ, et al. Prenatal Serum sFlt-1/PlGF Ratio Predicts the Adverse Neonatal Outcomes among Small-for-Gestational-Age Fetuses in Normotensive Pregnant Women: A Prospective Cohort Study. Medicine (Baltimore) 2021; 100: e24681.
Huerta I, Elías J, Campos K, et al. Maternal and Perinatal Characteristics of Pregnant Women with COVID-19 in a National Hospital in Lima, Peru. Rev Peru Ginecol y Obstet 2020; 66: 19–24.
Ni W, Yang X, Yang D, et al. Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19. Crit Care 2020; 24: 422.
Copyright (c) 2023 Sisca Puji Rahayu, Angga Mardro Raharjo, Dita Diana Parti, Yuli Hermansyah, Pipiet Wulandari, Nurul Istinaroh
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (